Josh Schultz, Corporate VP Strategic Partnerships, recorded at Partnerships in Clinical Trials

June 6, 2012
Josh Schultz of PAREXEL discusses: What biopharmaceutical companies are looking for, major benefits and core success factors, and who benefits from the strategic models. Recorded at 21st Annual Partnerships in Clinical Trials March 4-7, 2012 at the Marriott World Center Resort in Orlando, Florida. For more videos, go to http://www.PAREXEL.com/news-and-events/video-series/
Previous Video
PAREXEL CEO Josef H. von Rickenbach Rings Bell at NASDAQ Market Opening
PAREXEL CEO Josef H. von Rickenbach Rings Bell at NASDAQ Market Opening

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and...

Next Video
Overcoming Early Phase Challenges in Alzheimer's Studies
Overcoming Early Phase Challenges in Alzheimer's Studies

Dr. Larry Ereshefsky, Vice President, Principal Pharmacologist, and Global Psychiatric Therapeutic Leader, ...